[Form 4] Parker-Hannifin Corporation Insider Trading Activity

Rhea-AI Filing Summary

Jacobson Matthew A., Vice President & President of the Filtration Group at Parker-Hannifin Corporation (PH), was granted 4,444 Stock Appreciation Rights on 08/20/2025. The award shows a conversion/exercise reference price of $742.97, becomes exercisable beginning 08/20/2026, and expires on 08/19/2035. Following the grant the reporting person directly beneficially owns 4,444 rights. The filing explains the award vests in three equal annual installments beginning 08/20/2026. The Form 4 was signed via attorney-in-fact on 08/22/2025.

Positive

• Grant of 4,444 Stock Appreciation Rights to the reporting officer
• Vesting schedule is specified: three equal annual installments beginning 08/20/2026

Negative

• None.

Insights

Compensation Analyst

TL;DR: Executive received a time‑based stock appreciation rights award of 4,444 units, vesting over three years.

The award granted on 08/20/2025 provides the reporting officer 4,444 Stock Appreciation Rights with a reference price of $742.97, exercisable from 08/20/2026 and expiring 08/19/2035. Vesting is clarified as three equal annual installments beginning 08/20/2026, indicating a multi‑year retention incentive. The structure (SARs, multi‑year vesting, long expiration) is typical for long‑term compensation but the filing contains no dollar value realized, payout mechanics, or link to performance conditions.

Corporate Governance Expert

TL;DR: A routine insider grant to an officer was reported; disclosure is straightforward and complete for the award parameters.

The Form 4 discloses the reporting person, role (VP & Pres‑Filtration Grp.), issuer (Parker‑Hannifin, PH), transaction date, quantity (4,444 SARs), exercise/conversion price ($742.97), exercisable date, expiration date, and vesting schedule. The filing is narrowly focused on the equity award details and does not include additional governance disclosures such as board approval context or linkage to performance metrics.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jacobson Matthew A.

(Last) (First) (Middle)

6035 PARKLAND BOULEVARD

(Street)

CLEVELAND OH 44124

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Parker-Hannifin Corp [ PH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP & Pres-Filtration Grp.

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Rights	$742.97	08/20/2025		A		4,444		08/20/2026(1)	08/19/2035	Common Stock	4,444	$0	4,444	D

Explanation of Responses:

1. The Stock Appreciation Rights award vests in three equal annual installments beginning 8/20/26.

	/s/Stephanie R. Breitenbach, Attorney-in-Fact	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Jacobson Matthew A. report on the Form 4 for PH?

The Form 4 reports a grant of 4,444 Stock Appreciation Rights to Jacobson Matthew A., an officer of Parker‑Hannifin (PH).

When was the transaction dated and when do the SARs become exercisable?

The transaction date is 08/20/2025, and the SARs become exercisable beginning 08/20/2026.

What is the exercise/conversion price and expiration date of the award?

The filing lists a conversion/exercise reference price of $742.97 and an expiration date of 08/19/2035.

How do the SARs vest according to the Form 4?

The award vests in three equal annual installments beginning 08/20/2026.

How many SARs does the reporting person beneficially own after the transaction?

The reporting person directly beneficially owns 4,444 rights following the reported transaction.